NTMT1 and glioma: NRMT was highly expressed in two neurological tumors, brain lower grade glioma and glioblastoma multiforme, and poorly expressed in 3 (9.1%) of 33 tumors, but not differentially expressed in the remaining 11 tumor types (Fig. 1A).